First-line avelumab plus chemotherapy in patients with advanced solid tumors: results from the phase 1b/2 JAVELIN Chemotherapy Medley study.
Duncan A WheatleyRossana BerardiMiguel A Climent DuranAnna TomiakAlastair P GreystokeAnthony M JoshuaHendrick-Tobias ArkenauLajos GécziJavier García CorbachoLuis G Paz-AresSyed Anwer HussainLubos PetruželkaAngelo DelmonteColombe ChappeyJoanna C MastersElisabete MichelonDanielle A MurphySandrine MwewaRossano CesariBernard DogerPublished in: Cancer research communications (2024)
gov identifier, NCT03317496.